LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Industry

Global Medical Gas Analyzers Market to Reach USD 325 Million by 2025

The global medical gas analyzers market was valued at USD 235 million in 2017 and is expected to grow at a CAGR of 4.1% from 2018 to 2025 to reach USD 325 million by 2025, driven by an upsurge in the adoption of medical gas analyzers, stringent regulations for medical gas systems, and increase in demand for advanced medical gas analyzing systems. An increase in the number of medical gas therapies due to a surge in the number of patients treated in intensive care units (ICUs), neonatal intensive care units (NICUs), and emergency departments, as well as a surge in number of hospitals & surgery centers will further support the market growth. More...
01 Oct 2018
Image: The global hemostasis/coagulation analyzers market is expected to grow to USD 9.55 billion by 2026, driven mainly by the growing incidence of blood disorders (Photo courtesy of Analyticon Biotechnologies.

Global Hemostasis/Coagulation Analyzers Market to Reach USD 9.5 Billion by 2026

The global hemostasis/coagulation analyzers market was valued at USD 3.65 billion in 2017 and is expected to grow at a CAGR of 9.9% over the period 2018 to 2026 to reach USD 9.55 billion by 2026, driven mainly by the growing incidence of blood disorders. Technological innovations and miniaturization has led to the commercialization of several novel devices that have quick turnaround time and can also be used in point of care (POC) settings. Additionally, growing awareness and demand for technologically advanced medical treatments, government support and increasing adoption of laboratory automation are driving the demand for novel coagulation analyzers. More...
01 Oct 2018
Image: Handheld hematology devices are expected to contribute to the growth of the global POC hematology diagnostics market (Photo courtesy of Philips Healthcare).

Increasing Conditions and Diseases Drive Global POC Hematology Diagnostics Market

The global Point of Care (POC) hematology diagnostics market is expected to grow at a CAGR of close to 9% over the forecast period 2018-2022 to reach a value of USD 2.7 billion by 2022, driven mainly by the rising prevalence of hematology conditions and infectious diseases such as sickle cell disease, thalassemia, and polycythemia. Additionally, the increased adoption of next-generation hematology diagnostic products such as handheld hematology devices and non-invasive hematology testing will further contribute to the growth of the global POC hematology diagnostics market. More...
20 Sep 2018
Image: The western blotting processors market is expected to grow from USD 200 million to USD 329 million by 2028 (Photo courtesy of Next Advance).

Western Blotting Processors Market to Reach USD 329 Million by 2028

The western blotting processors market is projected to grow at a CAGR of 5.1% from an estimated USD 200 million in 2018 to just under USD 329 million towards the end of 2028, driven partly by the increasing cases of HIV globally as western blot is a confirmed test that can detect anti-HIV antibodies in blood serum samples. More...
20 Sep 2018

Global IVD Market to Reach USD 77 Billion by 2023

The worldwide market for in vitro diagnostic tests is estimated at USD 65 billion in 2018 and is expected to grow 4% annually to USD 77.8 billion by 2023, driven by the aging world population and stream of new test innovations, offset by reimbursement cuts globally and slower buying in the mature sectors. More...
12 Sep 2018
Image: The Connect.One network architecture allows labs to remotely monitor automated analyzers (Photo courtesy of Diagnostica Stago).

Stago Connect.One Network Allows Remote Monitoring of Analyzers

Diagnostica Stago, an in-vitro diagnostics company focusing on thrombosis and hemostasis, has launched the secure Connect.One network architecture, which allows laboratories to benefit from remote monitoring of their automated analyzers. More...
09 Aug 2018

DIAsource Immunoassays Enters Agreement with ZenTech for RIA Products

DIAsource Immunoassays, a BioVendor group company, has entered into a strategic agreement with ZenTech under which ZenTech will transfer its portfolio of radioimmunoassays (RIA) products to DIAsource, securing their continued production and sales. More...
31 Jul 2018
Visit expo >
Gold Member
Collection and Transport System
PurSafe Plus®
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gram-Negative Blood Culture Assay
LIAISON PLEX Gram-Negative Blood Culture Assay
Automatic Hematology Analyzer
DH-800 Series

In Other News



LabMedica Industry News channel reports on mergers and takeovers, on cooperative agreements and on trends in the IVD industry worldwide.
Copyright © 2000 - 2026 Globetech Media.
All rights reserved.